OrbiMed Capital GP IV LLC, Director at Anthera Pharmaceuticals Inc (ANTH), bought 5,700,000 shares at $0.66 ($3.8M) on 2013-01-30, disclosed to the SEC on 2013-02-01.
Open-market purchase of $3.8M ANTH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BOLD | SELL | 2018-03-12 | $10.2M | — | Filing → |
| BOLD | SELL | 2017-09-11 | $112K | — | Filing → |
| OTIC | SELL | 2015-11-24 | $5.7M | — | Filing → |